Home / Inspections / 1096432

FDA Inspection 1096432 — Brio Pharmaceuticals Inc

Brio Pharmaceuticals Inc — FEI 1628196

The FDA completed an inspection of Brio Pharmaceuticals Inc on July 11, 2019 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 11, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Houston, TX (United States)

Facility

Other inspections at this facility

  • 1304746 (VAI Fri Feb 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067624 (NAI Wed Oct 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 929358 (NAI Mon Jun 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 871072 (VAI Fri Mar 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 762066 (VAI Thu Jan 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources